The emerging role of cannabinoid neuromodulators in symptom management
- First Online:
- Cite this article as:
- Davis, M., Maida, V., Daeninck, P. et al. Support Care Cancer (2007) 15: 63. doi:10.1007/s00520-006-0180-0
The cannabinoids nabilone (Cesamet) and dronabinol (Marinol) are indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in cancer patients who have failed to respond adequately to conventional antiemetic therapy.
The endocannabinoid (CB) system interacts with numerous other systems and pharmaceutical cannabinoids target ubiquitous CB1 and CB2 receptors in the central nervous system and periphery, relieving nausea and vomiting and pain.
The benefits of this novel class of medications in cancer may extend beyond CINV, as indicated by data from preclinical studies and animal models.